The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Coherus Biosciences Inc (NASDAQ: CHRS) closed at $0.78 in the last session, down -5.44% from day before closing price of $0.82. In other words, the price has decreased by -$5.44 from its previous closing price. On the day, 2.36 million shares were traded. CHRS stock price reached its highest trading level at $0.8769 during the session, while it also had its lowest trading level at $0.7727.
Ratios:
We take a closer look at CHRS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on August 16, 2024, Downgraded its rating to Neutral and sets its target price to $1.50 from $4 previously.
On November 17, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’23 when Lanfear Dennis M sold 223,100 shares for $2.02 per share. The transaction valued at 449,770 led to the insider holds 731,693 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 89716360 and an Enterprise Value of 261901680. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29. Its current Enterprise Value per Revenue stands at 0.861 whereas that against EBITDA is -2.24.
Stock Price History:
Over the past 52 weeks, CHRS has reached a high of $3.70, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -19.27%, while the 200-Day Moving Average is calculated to be -54.19%.
Shares Statistics:
According to the various share statistics, CHRS traded on average about 2.52M shares per day over the past 3-months and 3380310 shares per day over the past 10 days. A total of 112.22M shares are outstanding, with a floating share count of 110.58M. Insiders hold about 4.02% of the company’s shares, while institutions hold 70.89% stake in the company. Shares short for CHRS as of 1730332800 were 31511462 with a Short Ratio of 12.52, compared to 1727654400 on 27963746. Therefore, it implies a Short% of Shares Outstanding of 31511462 and a Short% of Float of 31.919999999999998.
